Rough Day For the Biotechs

Today was rough for biotechs and healthcare stocks. The market was very erratic, with very inconsistent price movement throughout the session. Our open long signals were sharply lower despite the overall bullish trend in the equities markets. A good example of this is CMDO, which rallied sharply off of earnings news, only to decline just as sharply after the open. Here’s what happened.